DNA Microarray Market Size, Share, Growth 2024-2033| PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc

The DNA And Gene Chip Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The DNA And Gene Chip Market:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

According to The Business Research Company’s DNA And Gene Chip Global Market Report 2024, The dna and gene chip market size has grown rapidly in recent years. It will grow from $7.38 billion in 2023 to $8.4 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%.  The  growth in the historic period can be attributed to genomic research advancements, rise of personalized medicine, human genome project milestones, drug discovery and development, disease biomarker identification..

The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $13.7 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%.  The growth in the forecast period can be attributed to advancements in precision medicine, expansion of biomarker discovery, growth of personalized therapeutics, application in cancer research, increasing research funding.. Major trends in the forecast period include technological advancements, product innovations, regulatory framework and compliance, focus on rare diseases, continuous reduction in costs..

The rising demand for early cancer detection is significantly contributing to the growth of the DNA and gene market. Cancer is a broad class of conditions that can develop in practically any organ or tissue of the body when aberrant cells multiply uncontrollably, cross normal cell boundaries to invade nearby organs, and spread to other regions of the body. DNA and gene chips are used to measure gene expression patterns, determine the genetic and epigenetic landscape, and measure genomic regulatory elements bound by cancer transcription factors in cancerous cells. For instance, in 2022, according to the American Cancer Society, a US-based community-based, voluntary health organization, it is projected that there will be approximately 1.9 million newly diagnosed cancer cases and 609,360 deaths from cancer in the United States. Therefore, rising demand for early cancer detection is driving the growth of the DNA and gene chip market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

The dna and gene chip market covered in this report is segmented –

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

Strategic partnerships and collaborations are the key trends gaining popularity in the DNA and gene chip market. Many companies operating in this sector looking for partnerships to strengthen their position in the DNA and gene chip market. For instance, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, entered into a four-year strategic partnership with Wipro Limited, an India-based information technology company. Through this partnership, both companies execute the project titled Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer project-related genomics sequencing services. Further, in May 2022, Thermo Fisher Scientific, a US-based supplier of analytical instruments, partnered with Qatar Genome Program (QGP), a member of Qatar Foundation (QF)to develop an Axiom custom genotyping array for pan-Arab populations, utilizing whole genome sequencing data from 19 Arab countries. The array, with 800,000 variants, aims to enhance genomic research, focusing on conditions such as diabetes, cardiovascular diseases, autism, and cancer. The collaboration supports Qatar’s national vision for improved population health and the advancement of precision medicine for people of Arab identity worldwide. Thermo Fisher’s Axiom microarray technology facilitates accelerated precision medicine initiatives.

Major Players:

• PerkinElmer Inc.
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Macrogen Inc.
• Agilent Technologies Inc

The dna and gene chip market report table of contents includes:

1. Executive Summary
2. DNA And Gene Chip Market Characteristics
3. DNA And Gene Chip Market Trends And Strategies
4. DNA And Gene Chip Market – Macro Economic Scenario
5. Global DNA And Gene Chip Market Size and Growth.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Releted Reports:
https://topprnews.com/gas-phase-filtration-market-size/
https://topprnews.com/gas-to-liquid-gtl-systems-market-size/
https://topprnews.com/gas-treatment-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model